We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Takeda Pharmaceuticals is selling off some of its drugs in Japan in exchange for stock in a new venture to be helmed by Teva Pharmaceutical Industries. Read More
During a one-year period, the UK’s Medicines & Healthcare products Regulatory Agency conducted 47 inspections of pharma companies, during which they uncovered 27 critical findings, 169 major and 155 minor findings, according to a report. Read More
A House of Representatives committee is asking for a review of the FDA’s progress in ensuring the security of foreign facilities’ supply chains and toughening the agency’s approach to inspections at those facilities. Read More
Valeant’s access program with Walgreens, which the company says will make the company’s products affordable, is slated to kick off this Friday with dermatology brands, according to Ari Kellen, executive vice president and company group chairman. Read More
The FDA continues to turn up the heat on compounding pharmacies, issuing two warning letters to compounders in Kentucky and California for serious GMP deficiencies related to sterility. Read More